INCREASED IMMUNOSUPPRESSIVE VULNERABILITY IN ELDERLY RENAL TRANSPLANT RECIPIENTS1,2
Top Cited Papers
- 1 March 2000
- journal article
- research article
- Published by Wolters Kluwer Health in Transplantation
- Vol. 69 (5) , 885-889
- https://doi.org/10.1097/00007890-200003150-00037
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Tacrolimus versus cyclosporin for immunosuppression in renal transplantation: meta-analysis of randomised trialsBMJ, 1999
- SIROLIMUS (RAPAMYCIN)-BASED THERAPY IN HUMAN RENAL TRANSPLANTATIONTransplantation, 1999
- IMMUNOSUPPRESSIVE EFFECTS AND SAFETY OF A SIROLIMUS/CYCLOSPORINE COMBINATION REGIMEN FOR RENAL TRANSPLANTATION1Transplantation, 1998
- FK 506 as Primary Immunosuppressive Therapy in Renal TransplantationTransplantation Proceedings, 1998
- MULTICENTER RANDOMIZED TRIAL COMPARING TACROLIMUS (FK506) AND CYCLOSPORINE IN THE PREVENTION OF RENAL ALLOGRAFT REJECTION1Transplantation, 1997
- Mycophenolate mofetil for the prevention of acute rejection of primary cadaveric kidney transplants: Status of the MYC 1866 study at 1 yearTransplantation Proceedings, 1997
- FK 506 in kidney transplantation: Results of the U.S.A. randomized comparative phase III studyTransplantation Proceedings, 1997
- A BLINDED, RANDOMIZED CLINICAL TRIAL OF MYCOPHENOLATE MOFETIL FOR THE PREVENTION OF ACUTE REJECTION IN CADAVERIC RENAL TRANSPLANTATION1Transplantation, 1996
- SURVIVAL EXPERIENCE AMONG ELDERLY END-STAGE RENAL DISEASE PATIENTSTransplantation, 1995
- Placebo-controlled study of mycophenolate mofetil combined with cyclosporin and corticosteroids for prevention of acute rejectionThe Lancet, 1995